Dravet syndrome (DS) is a developmental and epileptic encephalopathy with evolving
disease course as individuals age. In recent years, the treatment landscape of DS has …

Following the approval of Epidiolex®(cannabidiol; CBD) for the treatment of seizures
associated with Lennox–Gastaut syndrome (LGS), Dravet syndrome (DS), and tuberous …

Fenfluramine hydrochloride has classically been described as acting pharmacologically
through a serotonergic mechanism. Therefore, it was initially used as an anorectic drug …

Background and Objectives Relative to the pediatric population, there is limited information
about Dravet syndrome (DS) in adults. In addition to some of the gait abnormalities reported …

Aim This cohort study aimed to describe functional mobility in Dravet syndrome, a
developmental and epileptic encephalopathy. Method Functional mobility was assessed in …

Aim To investigate the relation between cognitive and motor development in preschool aged
children with Dravet syndrome, in particular between the age of independent walking and …

This study aims to describe the main cognitive and behavioral comorbidities of Dravet
syndrome (DS) and Lennox–Gastaut syndrome (LGS), their impact on the health-related …

Dravet syndrome (DS) is a rare severe epilepsy syndrome associated with slowed
psychomotor development and behavioral disorders from the second year onward in a …

Abstract Background Dravet Syndrome (DS) is a developmental and epileptic
encephalopathy starting in infancy and characterised by treatment resistant epilepsy with …

Dravet syndrome (DS) is a developmental and epileptic encephalopathy associated with
variants in the voltage-gated sodium channel alpha 1 subunit (SCN1A) gene in around 90 …